MLchartDataset catalogue

bispecific monoclonal antibody ASP2074

Term · Oncology and biomedicine · MLC-T-ONC-012046

A bispecific monoclonal antibody directed against as of yet unknown targets, with potential antineoplastic activity. Upon administration, bispecific monoclonal antibody ASP2074 may, through as of yet unelucidated mechanisms of action, enhance cellular immune responses against susceptible tumor cells, resulting in increased tumor cell lysis.

Table 1. Record
IdentifierMLC-T-ONC-012046
FieldOncology and biomedicine
Synonymsbispecific antibody ASP2074
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-012046",
  "term": "bispecific monoclonal antibody ASP2074",
  "field": "Oncology and biomedicine",
  "definition": "A bispecific monoclonal antibody directed against as of yet unknown targets, with potential antineoplastic activity. Upon administration, bispecific monoclonal antibody ASP2074 may, through as of yet unelucidated mechanisms of action, enhance cellular immune responses against susceptible tumor cells, resulting in increased tumor cell lysis.",
  "synonyms": [
    "bispecific antibody ASP2074"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/bispecific-monoclonal-antibody-asp2074/"
}

Record 3,625 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.